NPPA fixes retail price of 12 combo drugs including Aspirin, Atorvastatin, Metformin; Details Farhat Nasim17 Nov 2019 7:38 AM GMTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details Medical Dialogues Bureau15 Nov 2019 10:59 AM GMTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
Morepen Labs adds blockbuster Rivaroxaban, Vildagliptin, UDCA to API portfolio Farhat Nasim14 Oct 2019 8:06 AM GMTWhile two products Rivaroxaban and Vildagliptin will augment Morepen Lab's presence in the cardiac and diabetic segments respectively, the third...
Fight for Vildagliptin: Natco goes to court against Novartis Farhat Nasim7 Sep 2019 11:02 AM GMTMumbai: Throwing an indirect challenge at patent holder Novartis, drugmaker Natco Pharma has submitted a fresh application in a Hyderabad court...
Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors Farhat Nasim30 July 2019 8:38 AM GMTNew Delhi: The patent protection of blockbuster anti-diabetic drug Vildagliptin manufactured by the Swiss drugmaker, Novartis, will soon expire on...
CDSCO Committee turns down Novartis FDC drug including Vildagliptin, Metformin, Glimepiride Farhat Nasim11 July 2019 12:08 PM GMTNew Delhi: The Swiss drugmaker, Novartis recently presented before the Central Drugs Standard Control Organization(CDSCO) Technical Committee to seek...
4 Pharma Giants face price fixing allegations on Vidagliptin: CCI starts probe Ruby Khatun Khatun15 Dec 2017 11:45 AM GMTMumbai: Trouble is mounting for 4 big pharma companies over price fixing of an anti-diabetic drug. An investigation has initiated on drug makers...
Novartis, Abbott, Emcure face allegations of cartelisation in anti-diabetes drug Vildagliptin savita thakur thakur26 March 2017 6:03 AM GMTThe Swiss drug maker Novartis and US based Abbott along with domestic companies Emcure and USV Pharma are under the lens of Health Ministry and...
